Clinical Translation of Optical Molecular Imaging to Tissue Engineering: Opportunities &amp; Challenges

Mary-Ann Mycek; Mary-Ann Mycek

doi:10.1364/BODA.2015.OT1C.1

Optics in the Life Sciences
OSA Technical Digest (online) (Optica Publishing Group, 2015),
paper OT1C.1
•https://doi.org/10.1364/BODA.2015.OT1C.1

Clinical Translation of Optical Molecular Imaging to Tissue Engineering: Opportunities & Challenges

Mary-Ann Mycek

Bio-Optics: Design and Application 2015

Vancouver Canada
12–15 April 2015
ISBN: 978-1-55752-954-1

From the session
Imaging using Endogenous Contrast (OT1C)

Not Accessible

Your library or personal account may give you access

Get PDF
Email
Share
Get Citation
Copy Citation Text
M. Mycek, "Clinical Translation of Optical Molecular Imaging to Tissue Engineering: Opportunities & Challenges," in Optics in the Life Sciences, OSA Technical Digest (online) (Optica Publishing Group, 2015), paper OT1C.1.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Citation alert
Save article

Abstract

The development of optical molecular imaging tools to characterize engineered tissues has the potential to enhance research in the field and may help to overcome regulatory barriers to clinical translation of tissue engineered medical products.

PDF Article

More Like This

Label-Free Optical Molecular Imaging for Clinical Tissue Diagnostics

Mary-Ann Mycek
AW3H.1 CLEO: Applications and Technology (CLEO:A&T) 2015

Nonlinear Optical Molecular Imaging Assesses Living Engineered Tissue Local Viability

Leng-Chun Chen, William R. Lloyd, Shiuhyang Kuo, Hyungjin Myra Kim, Cynthia L. Marcelo, Stephen E. Feinberg, and Mary-Ann Mycek
NW1A.3 Nonlinear Optics (NLO) 2015

Label-Free Optical Molecular Imaging to Assess Engineered Tissues

Leng-Chun Chen, William R. Lloyd, Shiuhyang Kuo, Hyungjin Myra Kim, Cynthia L. Marcelo, Stephen E. Feinberg, and Mary-Ann Mycek
MT3C.7 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013

Previous Article Next Article